Ran Frenkel

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, 2 Nd Floor, Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Ran Frenkel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ran Frenkel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, Chief Dev. Officer Common Stock 168K $138K $0.82 Feb 28, 2022 Direct
Karyopharm Therapeutics Inc. EVP, Chief Dev. Officer Stock Option (right to buy) 90K Feb 28, 2022 Direct

Insider Reports Filed by Ran Frenkel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Feb 28, 2022 3 -$17K 4 Mar 2, 2022 EVP, Chief Dev. Officer
KPTI Karyopharm Therapeutics Inc. Feb 17, 2022 1 -$35.5K 4 Feb 22, 2022 EVP, Chief Dev. Officer
KPTI Karyopharm Therapeutics Inc. Feb 7, 2022 1 -$19.6K 4 Feb 9, 2022 EVP, Chief Dev. Officer